menu

Menu

Home Aims and Scope statement Editorial board Instructions for authors Statement of Informed consent Statement of Human and Animal Rights Editorial process and peer review Copyright and License - Index and Abstract service - Open Access How to submit your article Contacts Archive

Latest Articles

PAG. 2193.
Medica 3 / 2022

MANAGEMENT OF PATIENTS WITH ALLERGIC RHINITIS IN THE PRIMARY CARE SETTING: A CROSS-SECTIONAL MULTICENTER STUDY IN DAILY PRACTICE (THE MAPRAP STUDY)

PAG. 1725.
Medica 3 / 2022

COVID-19 AS A HEALTH EDUCATION CHALLENGE: A PERSPECTIVE CROSS-SECTIONAL STUDY

PAG. 1719.
Medica 3 / 2022

Effect of lamivudine combined with thymosin on postoperative recurrence of alcoholic hepatitis complicated with liver cancer

You are here: Archive 2016 Special Issue 1 Pag 613

Treatment of hormone-refractory prostate cancer by wild-type P53 gene in combination with che- motherapy: case report

  Pdf

Authors

Yongsong Guan*,1, Long Sun2, Hua Wu2, Weimin Pan2, Xiao Li1, Qing He1, Yuan Liu1

Departments

1West China Hospital of Sichuan University, Chengdu, Sichuan Province, China,610041; State Key Laboratory of Biotherapy, West China Medical School, Sichuan University, Gaopeng Street, Keyuan Road 4, Chengdu 610041, Sichuan Province,China - 2Minnan PET Center, The First Hospital of Xiamen, Fujian Medical University, Xiamen 316003, Fujian Province, China

Back